A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

M. A. Socinski; A. Ivanova; K. Bakri; J. Wall; M. Q. Baggstrom; T. A. Hensing; A. Mears; M. Tynan; J. Beaumont; A. H. Peterman; and H. B. Niell

首页> 外文期刊>Annals of Oncology >A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

【24h】

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

机译：II期随机对照试验比较了每3周卡铂/紫杉醇与每3周卡铂和每周紫杉醇治疗晚期非小细胞肺癌的比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The optimal schedule of taxane administration has been an area of active interest in several recent clinical trials.

机译：背景：紫杉烷类药物的最佳给药方案一直是最近几项临床试验中的一个重要领域。

著录项

来源
《Annals of Oncology》 |2006年第1期|104-109|共6页
作者
M. A. Socinski; A. Ivanova; K. Bakri; J. Wall; M. Q. Baggstrom; T. A. Hensing; A. Mears; M. Tynan; J. Beaumont; A. H. Peterman; and H. B. Niell;
展开▼
作者单位

Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill NC;

Evanston Northwestern Healthcare and Northwestern University Chicago IL USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer. [J] . Socinski MA, Ivanova A, Bakri K, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第1期

机译：随机期II试验比较每3周Carboplatin /紫杉醇，每3周Carboplatin和每周紫杉醇在先进的非小细胞肺癌中的每周紫杉醇。
2. Randomized phase II trial comparing carboplatin plus weekly paclitaxel and docetaxel alone in elderly patients with advanced non-small cell lung cancer: North Japan lung cancer group trial 0801 [J] . MaemondoM., InoueA., SugawaraS., The oncologist . 2014,第4期

机译：老年晚期晚期非小细胞肺癌患者比较卡铂联合每周紫杉醇和紫杉醇单独治疗的随机II期试验：北日本肺癌组试验0801
3. Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801 [J] . Makoto Maemondo, Akira Inoue, Shunichi Sugawara, The oncologist . 2014,第4期

机译：比较卡铂加每周紫杉醇和多西他赛治疗老年晚期非小细胞肺癌老年患者的随机第二阶段试验：北日本肺癌组试验0801
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Long-term smoking-mediated downregulation of Smad3 induces tumorigenicity and carboplatin resistance in non-small cell lung cancer [D] . Samanta, Debangshu. 2012

机译：长期吸烟介导的Smad3的下调诱导非小细胞肺癌的致瘤性和卡铂耐药性
6. Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801 [O] . Makoto Maemondo, Akira Inoue, Shunichi Sugawara, 2014

机译：比较卡铂联合每周紫杉醇和多西他赛治疗老年晚期非小细胞肺癌老年患者的随机第二阶段试验：北日本肺癌组试验0801
7. Weekly Paclitaxel Combined with Carboplatin Versus the Standard Every 3-Weeks Paclitaxel and Carboplatin for Elderly Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer. [O] . Hala El-Shenshawy, Saleh Taema, Eman El-Zahaf, 2011

机译：每周紫杉醇与Carboplatin相结合，每3周紫杉醇和卡铂都会为老年人以前未经治疗的先进的非小细胞肺癌。

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅